During the past decade, Keio University Hospital conducted 110 clinical trials. In the 10-year time frame, 110 clinical trials started and 53 clinical trials were completed, i.e. on average, 48.2% percent of trials that started reached the finish line to date. In the past 5 years, 58 clinical trials started and 40 clinical trials were completed. i.e. 69% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Keio University Hospital" #1 sponsor was "Pfizer" with 22 trials, followed by "Hoffmann-La Roche" with 8 trials sponsored, "Takeda" with 7 trials sponsored, "Merck Sharp & Dohme LLC" with 5 trials sponsored and "Shire" with 5 trials sponsored. Other sponsors include 98 different institutions and companies that sponsored additional 72 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Keio University Hospital" #1 collaborator was "Astellas Pharma Inc" with 4 trials as a collaborator, "Merck Sharp & Dohme LLC" with 3 trials as a collaborator, "Eisai Inc." with 2 trials as a collaborator, "Eli Lilly and Company" with 2 trials as a collaborator and "Galapagos NV" with 2 trials as a collaborator. Other collaborators include 77 different institutions and companies that were collaborators in the rest 80 trials.

According to Clinical.Site data, the most researched conditions in "Keio University Hospital" are "Crohn's Disease" (6 trials), "Rheumatoid Arthritis" (5 trials), "Systemic Lupus Erythematosus" (5 trials), "Ulcerative Colitis" (5 trials) and "Carcinoma, Renal Cell" (4 trials). Many other conditions were trialed in "Keio University Hospital" in a lesser frequency.

Most popular intervention types in "Keio University Hospital" are "Drug" (123 trials), "Device" (17 trials), "Other" (14 trials), "Biological" (13 trials) and "Procedure" (6 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (35 trials), "Atezolizumab" (8 trials), "Pembrolizumab" (7 trials), "Bevacizumab" (5 trials) and "Carboplatin" (4 trials). Other intervention names were less common.

The vast majority of trials in "Keio University Hospital" are 130 trials for "All" genders, 12 trials for "Female" genders and 8 trials for "Male" genders.

Currently, there are NaN active trials in "Keio University Hospital". 1 are not yet recruiting, 28 are recruiting, 33 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 72 completed trials in Keio University Hospital, undefined suspended trials, and 14 terminated clinical trials to date.

Out of the total trials that were conducted in Keio University Hospital, 7 "Phase 1" clinical trials were conducted, 40 "Phase 2" clinical trials and 84 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 6 trials, and there were also 12 trials that are defined as “Not Applicable".